Endocrine fibroblast growth factors as potential biomarkers for chronic kidney disease.

Expert Review of Molecular Diagnostics
Yuichiro KondoM Fukagawa

Abstract

Among the family of fibroblast growth factors (FGFs), FGF19, FGF21, and FGF23 act as circulating hormones and are called endocrine FGFs. FGF19 and FGF21 regulate bile acid and energy homeostasis, respectively, whereas FGF23 regulates vitamin D and phosphate homeostasis. Accumulating evidence suggests that FGF23 plays a critical role in disturbed mineral metabolisms, left ventricular hypertrophy, immunosuppression, inflammation, among others in patients with chronic kidney disease (CKD), highlighting the potential both as a biomarker and a therapeutic target. Several studies have also examined the potential role of FGF19 and FGF21 in CKD patients. In this review, we present a brief overview of the biology of FGF19, FGF21, and FGF23, and summarize recent clinical and experimental studies on the pathophysiological roles of endocrine FGFs, mainly FGF23, in CKD patients. Among the endocrine FGFs, FGF23 represents the most promising biomarker in CKD patients. If future studies confirm that FGF23 is directly toxic in CKD patients, FGF23 could be regarded as a therapeutic target and its measurement would be valuable if applied in clinical practice. Despite their potentially important roles, the clinical relevance of FGF19 and FGF21 in ...Continue Reading

References

Jun 21, 1996·The Journal of Biological Chemistry·D M OrnitzM Goldfarb
Dec 1, 1996·Journal of the American Society of Nephrology : JASN·T A IkizlerR M Hakim
Aug 1, 1997·The Journal of Clinical Endocrinology and Metabolism·R NehgmeT O Carpenter
Feb 5, 1999·Biochimica Et Biophysica Acta·T NishimuraN Itoh
May 18, 2000·The New England Journal of Medicine·W G GoodmanI B Salusky
Jun 20, 2000·Biochimica Et Biophysica Acta·T NishimuraN Itoh
Sep 29, 2000·Circulation Research·S JonoC M Giachelli
Feb 13, 2001·Biochemical and Biophysical Research Communications·N KohY Nabeshima
Apr 24, 2001·Journal of the American Society of Nephrology : JASN·Rachel J MiddletonRobert N Foley
May 10, 2001·Proceedings of the National Academy of Sciences of the United States of America·T ShimadaT Yamashita
Apr 25, 2003·The New England Journal of Medicine·Kenneth B JonssonHarald Jüppner
Mar 26, 2004·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Takashi ShimadaTakeyoshi Yamashita
Jul 21, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Takashi ShigematsuMasafumi Fukagawa
Jul 31, 2004·Journal of the American Society of Nephrology : JASN·Geoffrey A BlockGlenn M Chertow
Sep 24, 2004·The New England Journal of Medicine·Alan S GoChi-yuan Hsu
Oct 12, 2004·Trends in Genetics : TIG·Nobuyuki Itoh, David M Ornitz
Dec 23, 2004·The Journal of Clinical Endocrinology and Metabolism·Serge L FerrariRené Rizzoli
May 3, 2005·Cytokine & Growth Factor Reviews·Moosa MohammadiOmar A Ibrahimi
May 20, 2005·The Journal of Clinical Investigation·Alexei KharitonenkovArmen B Shanafelt
May 27, 2005·Journal of the American Society of Nephrology : JASN·Orlando GutierrezMyles Wolf
Jul 16, 2005·American Journal of Physiology. Gastrointestinal and Liver Physiology·Olga I KolekFayez K Ghishan
Aug 4, 2005·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Fumihiko KoiwaUNKNOWN ROD21 Clinical Research Group
Nov 2, 2005·Journal of Bone and Mineral Metabolism·Nobuaki ItoToshiro Fujita
Dec 27, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Hirokazu HondaBengt Lindholm
Jan 27, 2006·The Journal of Biological Chemistry·Hiroshi KurosuMakoto Kuro-o
Nov 7, 2006·Nature·Itaru UrakawaTakeyoshi Yamashita
Apr 25, 2007·Proceedings of the National Academy of Sciences of the United States of America·Yasushi OgawaMakoto Kuro-o
Jul 14, 2007·The Journal of Biological Chemistry·Benjamin C LinLuc R Desnoyers
Jul 28, 2007·Journal of the American Society of Nephrology : JASN·Danilo FliserPeter Riegler
Jun 3, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Francesca TentoriFriedrich K Port
Aug 9, 2008·The New England Journal of Medicine·Orlando M GutiérrezMyles Wolf
Oct 9, 2008·Diabetes Care·Sebastian SteinMathias Fasshauer
Feb 14, 2009·The American Journal of the Medical Sciences·Heng Jung Hsu, Mai-Szu Wu
Feb 28, 2009·Nature Reviews. Drug Discovery·Andrew Beenken, Moosa Mohammadi
May 12, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Majd A I MirzaTobias E Larsson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.